Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3212]

'Overturning established fact' leads to new target in MLL-rearranged leukaemia

'Overturning established fact' leads to new target in MLL-rearranged leukaemia

Carfilzomib with dexamethasone receives NICE recommendation for use at first relapse of MM

Carfilzomib with dexamethasone receives NICE recommendation for use at first relapse of MM

Mouse models show HDAC inhibitors may benefit Ph leukaemia patients

Mouse models show HDAC inhibitors may benefit Ph leukaemia patients

New cellular imaging paves way for cancer treatment

New cellular imaging paves way for cancer treatment

Five years before brain cancer diagnosis, changes detectable in blood

Five years before brain cancer diagnosis, changes detectable in blood

ASCO 2017: Early research suggests first immunotherapy for mesothelioma on the horizon

ASCO 2017: Early research suggests first immunotherapy for mesothelioma on the horizon

ASCO 2017: Car T-cell therapy sends multiple myeloma into lasting remission

ASCO 2017: Car T-cell therapy sends multiple myeloma into lasting remission

ASCO 2017: Web-based system for self-reporting symptoms helps patients live longer

ASCO 2017: Web-based system for self-reporting symptoms helps patients live longer

ASCO 2017: Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

ASCO 2017: Larotrectinib shows durable efficacy across diverse paediatric and adult cancers

ASCO 2017: Personalised therapy with ibrutinib achieves complete remission in many CLL patients

ASCO 2017: Personalised therapy with ibrutinib achieves complete remission in many CLL patients

More from ecancer